BR0007514A - Macrolìdeos com atividade anti-inflamatória - Google Patents

Macrolìdeos com atividade anti-inflamatória

Info

Publication number
BR0007514A
BR0007514A BR0007514-0A BR0007514A BR0007514A BR 0007514 A BR0007514 A BR 0007514A BR 0007514 A BR0007514 A BR 0007514A BR 0007514 A BR0007514 A BR 0007514A
Authority
BR
Brazil
Prior art keywords
inflammatory activity
macrolides
macrolydes
oximino
dimethylamino
Prior art date
Application number
BR0007514-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Franco Pellacini
Daniela Botta
Stefano Romagnano
Moriggi Ermanno
Lorenzo Pradella
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of BR0007514A publication Critical patent/BR0007514A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
BR0007514-0A 1999-01-15 2000-01-12 Macrolìdeos com atividade anti-inflamatória BR0007514A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000061A IT1306205B1 (it) 1999-01-15 1999-01-15 Macrolidi ad attivita' antiinfiammatoria.
PCT/EP2000/000163 WO2000042055A2 (en) 1999-01-15 2000-01-12 Macrolides with anti-inflammatory activity

Publications (1)

Publication Number Publication Date
BR0007514A true BR0007514A (pt) 2001-11-20

Family

ID=11381492

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0007514-0A BR0007514A (pt) 1999-01-15 2000-01-12 Macrolìdeos com atividade anti-inflamatória

Country Status (19)

Country Link
US (1) US6455576B1 (enExample)
EP (1) EP1144427B1 (enExample)
JP (1) JP4568433B2 (enExample)
CN (1) CN1151165C (enExample)
AT (1) ATE308552T1 (enExample)
AU (1) AU769006B2 (enExample)
BR (1) BR0007514A (enExample)
CA (1) CA2368400C (enExample)
DE (1) DE60023647T2 (enExample)
ES (1) ES2251966T3 (enExample)
HU (1) HU229228B1 (enExample)
IL (2) IL144044A0 (enExample)
IT (1) IT1306205B1 (enExample)
MX (1) MXPA01007164A (enExample)
NO (1) NO318982B1 (enExample)
RU (1) RU2243230C2 (enExample)
SK (1) SK286772B6 (enExample)
WO (1) WO2000042055A2 (enExample)
ZA (1) ZA200105748B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
NZ537717A (en) 2002-07-08 2006-04-28 Pliva Istrazivacki Inst D New compounds, compositions and methods for treatment of inflammatory diseases and conditions
PL374646A1 (en) * 2002-07-08 2005-10-31 Pliva-Istrazivacki Institutt D.O.O. Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use
DE60327341D1 (de) * 2002-07-08 2009-06-04 Glaxosmithkline Zagreb Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
ITMI20022292A1 (it) * 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
CA2521462A1 (en) 2003-04-17 2004-10-28 Sandoz Ag Derivatives of azithromycin
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
ITMI20040124A1 (it) * 2004-01-29 2004-04-29 Zambon Spa Macrolidi ad attivita' antiinfiammatoria
WO2006130128A2 (en) * 2004-02-18 2006-12-07 Chiron Corporation Methods of identifying anti-inflammatory macrolides
JP5383037B2 (ja) 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ,インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法
WO2006035301A2 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Erythromycin a derivatives as antibacterial agents
WO2006046123A2 (en) 2004-10-27 2006-05-04 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugates with anti-inflammatory activity
US20080249034A1 (en) * 2005-03-21 2008-10-09 Zambon S.P.A. Use of Macrolides for Treating Intestinal Inflammation
US7582611B2 (en) * 2005-05-24 2009-09-01 Pfizer Inc. Motilide compounds
WO2011090940A1 (en) 2010-01-19 2011-07-28 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
RU2455309C2 (ru) * 2010-07-20 2012-07-10 Открытое Акционерное Общество "Татхимфармпрепараты" Способ получения аморфной формы рокситромицина
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds
US11771677B2 (en) 2020-03-12 2023-10-03 Zoetis Services Llc Immunomodulating urea azalides
US20230131943A1 (en) 2020-03-24 2023-04-27 Burnet Micheal W Anti-infective and anti-viral compounds and compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928387A (en) * 1974-02-04 1975-12-23 Hoffmann La Roche Antibiotic 1745A/X and methods for the production thereof
IT1189285B (it) * 1982-05-28 1988-02-04 Nuovo Consor Sanitar Nazionale Sali dell'antibiotico eritromicina e del suo estere propionico con acidi ad attivita' terapeutica coadiuvante
EP0254534A3 (en) * 1986-07-24 1991-04-17 William S. Robinson Erythromycin derivatives and compositions and use for inhibiting virus replication and disease
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
KR19980701895A (ko) * 1995-03-08 1998-06-25 이라우치지마 가즈다카 면역관련병 처치제 및 그의 탐색 방법

Also Published As

Publication number Publication date
ATE308552T1 (de) 2005-11-15
WO2000042055A3 (en) 2001-09-07
HUP0105105A2 (hu) 2002-04-29
JP2002534531A (ja) 2002-10-15
ES2251966T3 (es) 2006-05-16
SK286772B6 (sk) 2009-05-07
MXPA01007164A (es) 2002-03-27
EP1144427B1 (en) 2005-11-02
EP1144427A2 (en) 2001-10-17
CA2368400A1 (en) 2000-07-20
JP4568433B2 (ja) 2010-10-27
ZA200105748B (en) 2002-10-14
DE60023647D1 (de) 2005-12-08
IT1306205B1 (it) 2001-05-30
HU229228B1 (en) 2013-09-30
AU769006B2 (en) 2004-01-15
CN1336932A (zh) 2002-02-20
US6455576B1 (en) 2002-09-24
DE60023647T2 (de) 2006-08-10
EP1144427A3 (en) 2002-08-28
RU2243230C2 (ru) 2004-12-27
IL144044A0 (en) 2002-04-21
ITMI990061A1 (it) 2000-07-15
SK9812001A3 (en) 2002-01-07
NO318982B1 (no) 2005-05-30
IL144044A (en) 2006-12-31
WO2000042055A2 (en) 2000-07-20
NO20013517L (no) 2001-07-16
CN1151165C (zh) 2004-05-26
CA2368400C (en) 2007-06-05
AU2663600A (en) 2000-08-01
NO20013517D0 (no) 2001-07-16
HUP0105105A3 (en) 2003-05-28

Similar Documents

Publication Publication Date Title
BR0007514A (pt) Macrolìdeos com atividade anti-inflamatória
DE69925133D1 (de) Pyrrolobenzodiazepine
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
DE69836424D1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
BR9801652A (pt) Resorcinil-triazinas
DE69104777D1 (de) Orale Arzneimittelformen von biologisch aktiven Eiweisstoffen.
ATE233274T1 (de) Oxyiminopregnancarbolactone
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
PT1119557E (pt) Derivados de indeno- nafto- e benzociclohepta-di-hidrotiazole sua preparacao e sua utilizacao como medicamentos anorecticos
IT1229195B (it) Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
IT1285770B1 (it) Composti corticoidei
EP0569862A3 (en) Self-adhesive medical sheet and medical preparation.
ITMI20022292A1 (it) 9a-azalidi ad attivita' antiinfiammatoria.
IT9019754A0 (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
NO980296D0 (no) Forbedrede terapeutiske midler
BR9812160A (pt) Derivados de benzoxazina e benzotiazina e seu emprego em medicamentos
PT986386E (pt) Uso de derivados heterociclicos aromaticos com azoto no tratamento topico de doencas dos tecidos epiteliais
BR9814188A (pt) "agonistas de 5-ht1f"
ITRM990339A0 (it) Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali deriva
ATE241640T1 (de) Fusidinsäure-derivate
FR2800276B1 (fr) Composition et medicament, notamment anti-inflammatoire, constitue de ladite composition
ITMI911097A0 (it) Composizioni terapeutiche ad attivita' anti-hiv costituite da 2',3'-didesossiadenosia e sostanze inibitrici della adenossina- deaminasi
IT1252626B (it) ¬3h, 7h| tiazolo ¬3,4a| piridine ad attivita' antiasmatica ed antiinfiammatoria delle vie aeree

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O ART .8O COMBINADO COM ART. 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 16A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2342 DE 24-11-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.